Test Code MRDMR Multiple Myeloma Minimal Residual Disease by Flow Cytometry, Bone Marrow
Specimen Required
Only orderable as a reflex. For more information see MSMRD / Myeloma Stratification and Risk-Adapted Therapy with Reflex to Minimal Residual Disease, Bone Marrow
Specimen Type: Redirected bone marrow
Container/Tube:
Preferred: Yellow top (ACD solution A or B)
Acceptable: Lavender top (EDTA)
Specimen Volume: 4 mL
Secondary ID
616031Useful For
Detecting low level (minimal residual disease) myeloma cells after therapy to confirm remission has been achieved
Method Name
Only orderable as a reflex. For more information see MSMRD / Myeloma Stratification and Risk-Adapted Therapy with Reflex to Minimal Residual Disease, Bone Marrow
Immunophenotyping
Reporting Name
Multiple Myeloma MRD by Flow, BMSpecimen Type
Bone MarrowSpecimen Minimum Volume
2 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Bone Marrow | Ambient (preferred) | 72 hours | |
Refrigerated | 72 hours |
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Reference Values
Only orderable as a reflex. For more information see MSMRD / Myeloma Stratification and Risk-Adapted Therapy with Reflex to Minimal Residual Disease, Bone Marrow
An interpretive report will be provided.
Day(s) Performed
Preanalytical processing: Monday through Saturday
Results reported: Monday through Friday
Report Available
2 to 4 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
88184-Flow Cytometry; first cell surface, cytoplasmic or nuclear marker
88185 x 9-Flow Cytometry; additional cell surface, cytoplasmic or nuclear marker
88188-Flow Cytometry Interpretation, 9 to 15 Markers
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
MRDMR | Multiple Myeloma MRD by Flow, BM | 93022-2 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
CK146 | % Minimal Residual Disease (MRD) | 93021-4 |
CK147 | % Normal Plasma Cells (of total PC) | 93020-6 |
CK148 | Non-Aggregate Events | 38257-2 |
CK149 | Total Plasma Cell Events | 93019-8 |
CK150 | Poly PC Events | 93018-0 |
CK151 | Abnormal PC Events | 93017-2 |
615796 | % B-cell Precursors | 101131-1 |
615797 | % Mast Cells | 101130-3 |
616082 | Validated Assay Sensitivity | 101129-5 |
616083 | Lower Limit of Quantitation (LLOQ) | 87706-8 |
615798 | Patient / Sample Theoretical LOQ | 101128-7 |
614590 | Final Diagnosis | 74226-2 |